News

Today marks the beginning of the fifth and final year of the EuCARE project  Since its launch, EuCARE has connected researchers, clinicians, and institutions across the globe to better understand and respond to infectious diseases.As we enter this last year, our focus remains clear:🔬 advancing knowledge,🤝 strengthening collaboration, and💡 ensuring science continues to make a difference for […]

On September 26th, EuCARE and VIROMARKERS joined the European Researchers’ Night 2025 in Frascati 🇮🇹, part of NET – scieNcE Together 2024–2025. This annual event transforms Europe into a huge scientific laboratory, connecting researchers and citizens through interactive activities, science villages, and open labs across over 30 Italian cities. With Maria Skłodowska Curie as the

We are proud to share that our study, “Risk of Long COVID Symptoms and Conditions After SARS-CoV-2 Compared to Other Respiratory Viral Infections: A Systematic Review and Meta-Analysis”, was presented as a poster at the Nordic HIV & Virology Conference 2025. The research highlights:✅ Higher risk of long-term symptoms such as pulmonary embolism, fatigue, abnormal

A EuCARE survey with 2,079 HCWs across 🇵🇹 🇧🇷 🇩🇪 🇵🇱 🇱🇹 — led by Prof. Francis Drobniewski (Imperial College London) — revealed: What helped? Easy workplace access, clear scientific info, and seeing peers get vaccinated. 👉 One lesson: vaccine promotion must be tailored — not one-size-fits-all. Read the full manuscript here!

On August 25, EuCARE partners gathered prestigious seat of the Faculty of Medicine of UFMG, Belo Horizonte, for a dedicated Post Acute Infection Syndrome (PAIS) meeting. Julia Caporali (UFMG), Dario Corsini (EuResist), Francesca Incardona (EuResist), Jorge Pinto (UFMG) and Flavia Faleiro (UFMG) talked about the ongoing studies and perspectives.🔹 PAIS is attracting interest after the

Nordic HIV & Virology Conference 2025 | 24–26 September | Stockholm, Sweden 🇸🇪 The Nordic HIV & Virology Conference is back with another excellent scientific programme, bringing together leading experts to share the latest advancements in HIV and virology research. 💡 Key info:🔹 Deadline for abstract submission: 25 August 2025🔹 PhD students with accepted abstracts:

At EuCARE, we know that health and well-being are accompanied by moments of joy, rest, and sunshine. Wherever your summer takes you, take care, recharge your energy, and keep curiosity alive, because science never goes on vacation! ✨

Barcelona hosted the 23rd European Meeting on HIV & Hepatitis — and EuCARE was happy to endorse this event and share some results from the project.

Florian König (University of Tübingen) will present: 🎓 ClinIAN: Clinically Informed Attention Network A machine learning model using real-world COVID-19 data to improve patient risk prediction and care. Stay tuned for more information!

What drives persistent symptoms after COVID-19? A newly published study from the EuCARE team explores how SARS-CoV-2 RNAemia (the presence of viral RNA in the blood) and immune dysregulation may explain the early persistence of symptoms in unvaccinated, hospitalised patients. 📌 Key findings:– Patients with persistent symptoms had a weaker immune response and lower levels of